The prognostic value of the change in neutrophil-to-lymphocyte ratio during first-line palliative chemotherapy in patients with metastatic gastric cancer: A retrospective study.

Bozkurt, O; Firat, ST; Dogan, E; Cosar, RAMAZAN; Inanc, M; Ozkan, M

The prognostic value of the change in neutrophil-to-lymphocyte ratio during first-line palliative chemotherapy in patients with metastatic gastric cancer: A retrospective study.

Atıf İçin Kopyala

Bozkurt O., Firat S., Dogan E., Cosar R., Inanc M., Ozkan M.

Journal of B.U.ON. : official journal of the Balkan Union of Oncology, cilt.24, ss.1992-1999, 2019 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 24
Basım Tarihi: 2019
Dergi Adı: Journal of B.U.ON. : official journal of the Balkan Union of Oncology
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.1992-1999
Erciyes Üniversitesi Adresli: Evet

Özet

Purpose: Metastatic gastric cancer (mGC) is linked with worse prognosis, and tools are needed for predicting disease course and chemotherapy response. The value of the change in the neutrophil-to-lymphocyte ratio (NLR) during first-line palliative chemotherapy on the outcomes in patients with mGC is not fully explained. This study aimed to investigate the importance of changes in NLR in predicting disease course and chemotherapy response in mGC.